Abstract| Volume 139, ISSUE 3, P586, December 2015

Download started.


Referrals to Genetic Counseling in Patients with Ovarian, Fallopian Tube, or Primary Peritoneal Cancer, an Institutional Review

      Introduction: In October 2014, the SGO endorsed genetic testing for all individuals with epithelial ovarian, fallopian tube, or primary peritoneal cancer (EOC). Limited studies have shown genetic counseling (GC) referral rates of 20%. Genetic mutations involving 21 genes are thought to explain 24% of EOC. Our objective was to identify rates of GC referral and the incidence of gene mutations in patients (pts) with EOC at Hartford Hospital (HH) and The Hospital of Central Connecticut (HOCC).
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Gynecologic Oncology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect